CAS: 154924-17-1; 6-(Dimethylamino)Nicotinonitrile

该化合物是一种多用途的七环化合物,在6位置以二甲基氨基组替换一对丙烯核,在3位置以一对硝三联苯组取代一对丙烯基,这种结构具有独特的电子和消毒特性,使其成为有机合成和制药研究的宝贵中间体.二甲基氨基组会提高电子密度,促进核生殖反应,而硝酸三联苯功能则为进一步衍生提供再活动.其定义明确的分子框架有利于在化学协调中构建复杂的乙基循环或离子.该化合物在普通有机溶剂中的稳定性和溶性进一步支持其在多种合成应用中的用途.

结构式图片

相似化合物

82846-28-4 149805-92-5 261715-36-0

上下游产品

6-chloronicotinonitrile dimethyl amine 5-bromo-2-dimethylaminopyridine ethyl 2-cyanoacetate 5-(aminomethyl)-N,N-dimethylpyridin-2-amine [1,2,4]triazolo[1,5-a]pyridin-6-ylmethanamine [1,2,4]triazolo[1,5-a]pyridine-6-carbonitrile 6-(dimethylamino)nicotine-3-carboxaldehyde

合成工艺路线路线简述

    📜2-氨基-5-氰基吡啶,N,N-二甲基甲酰胺二甲基缩醛 以 N,N-二甲基甲酰胺 用作溶剂,化学反应生成6-(二甲胺基)-3-氰基吡啶
    参考文献:Discovery Of (S)-1-(1-(Imidazo[1,2-A]Pyridin-6-yl)Ethyl)-6-(1-Methyl-1H-Pyrazol-4-yl)-1H-[1,2,3]Triazolo[4,5-B]Pyrazine (Volitinib) As A Highly Potent And Selective Mesenchymal-epithelial Transition Factor (C-Met) Inhibitor In Clinical Development For Treatment Of Cancer
    标题:Discovery Of (S)-1-(1-(Imidazo[1,2-A]Pyridin-6-yl)Ethyl)-6-(1-Methyl-1H-Pyrazol-4-yl)-1H-[1,2,3]Triazolo[4,5-B]Pyrazine (Volitinib) As A Highly Potent And Selective Mesenchymal-epithelial Transition Factor (C-Met) Inhibitor In Clinical Development For Treatment Of Cancer
    摘要:Hgf/c-Met Signaling Has Been Implicated In Human Cancers. Herein We Describe The Invention Of A Series Of Novel Triazolopyrazine C-Met Inhibitors. The Structure Activity Relationship Of These Compounds Was Investigated,Leading To The Identification Of Compound 28,Which Demonstrated Favorable Pharmacokinetic Properties In Mice And Good Antitumor Activities In The Human Glioma Xenograft Model In Athymic Nude Mice.
    Doi:10.1021/jm500510F

    海关参考信息

    专利信息


    专利号:US-11279687-B2
    优先权日:2010-09-03
    标题:Compounds and compositions for the inhibition of NAMPT
    发明人:BAIR KENNETH W; BAUMEISTER TIMM R; BUCKMELTER ALEXANDRE J; CLODFELTER KARL H; HAN BINGSONG; LIN JIAN; REYNOLDS DOMINIC J; SMITH CHASE C; WANG ZHONGGUO; ZHENG XIAOZHANG; YUEN PO-WAI
    权利人:VALO HEALTH INC; GENENTECH INC
    摘要:The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An embodiment of the invention is the provision of a compound of Formula IIIA.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知